Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)

• DOI: 10.1016/j.dld.2025.02.002
• Publication Date: 2025-03-04T20:24:38Z
• Authors: Thierry Lecomte; Bruno Giraudeau; Jean-Marc Phelip; Christophe Tourni...; Michel Ducreux; David Tougeron; Côme Lepage; Laurent Mineur; Philippe Laplaige; Romain Desgrippes; Pascal Artru; Christophe Borg; Marine Jary; Olivier Bouché; Jean-Philippe Metges; Rosine Guimbaud; Thomas Aparicio; Fanny Foubert; Vincent Hautefeuille; Marie Muller; Karine Bouhier-Le...; Rémi Darrius; Sarah Lobet; Fanny Monmousseau; Théodora Bejan-An...; Gilles Paintaud; David Ternant